Laboratory Corporation of America Holdings Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/11/2026)
| Balance Sheet | Total Assets | 18,392,700,000.00 | ROE | 46.87 % |
| Balance Sheet | Total Equity | 8,619,800,000.00 | ROA | 4.77 % |
| Cashflow | Capital Expenditures | -434,500,000.00 | P/FCF | 22.05 |
| Cashflow | Free Cash Flow | 1,206,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,640,500,000.00 | P/CF | 16.21 |
| Income | Earnings per Share (diluted) | 10.46 | Div. Yield | 0.91 % |
| Income | Net Income | 876,500,000.00 | P/E | 30.34 |
| Income | Shares Outstanding | 83,800,000.00 | P/B | 3.09 |
| Income | Total Revenue | 13,951,700,000.00 | P/S | 1.91 |
Ratios calculated on: 10/14/2026
Company Description
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.labcorp.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more